{"database": "lobbying", "table": "lobbying_activities", "rows": [[3238695, "9e19ad8c-dfed-4776-9085-2cd78e4297b4", "Q3", "WEST FRONT STRATEGIES LLC", 401103493, "VIATRIS INC", 2024, "third_quarter", "CPT", "Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2024-10-15T15:24:42-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3238695"], "units": {}, "query_ms": 0.4371779505163431, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}